Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Citrin

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cancer|November 15, 1986
Estramustine affects bone mineral metabolism in metastatic prostate cancerD L Citrin, C B Wallemark, R Nadler, et al.
Surgery, Gynecology & Obstetrics|September 1, 1976
Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary cancer of the breastD L Citrin, C M Furnival, R G Bessent, et al.
American Journal of Clinical Oncology|April 25, 2001
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885C Obasaju, J Manola, G R Hudes, et al.
The British Journal of Surgery|January 1, 1974
Preliminary experience of bone scanning with 99mTc-labelled polyphosphate in malignant diseaseD L Citrin, W R Greig, J F Calder, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
The British Journal of Radiology|February 1, 1975
A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant diseaseD L Citrin, R G Bessent, J B Tuohy, et al.
The Prostate|January 1, 1991
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trialD L Citrin, M I Resnick, P Guinan, et al.
The British Journal of Surgery|April 1, 1974
Proceedings: Comparison of 99Tc-labelled polyphosphate, pyrophosphate and ethane hydroxydiphosphonate in patients with skeletal metastasesD L Citrin, R G Bessent, J B Tuohy, et al.
The British Journal of Surgery|September 1, 1978
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancerJ H McKillop, L H Blumgart, C B Wood, et al.
Strahlentherapie. Sonderbande|January 1, 1975
Comparison of 99mTc-labelled polyphosphate, pyrophosphate and ethane hydroxy diphosphonate in patients with skeletal metastases and in normal subjectsD L Citrin, R G Bessent, J B Tuohy, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cancer|November 15, 1986
Estramustine affects bone mineral metabolism in metastatic prostate cancerD L Citrin, C B Wallemark, R Nadler, et al.
Surgery, Gynecology & Obstetrics|September 1, 1976
Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary cancer of the breastD L Citrin, C M Furnival, R G Bessent, et al.
American Journal of Clinical Oncology|April 25, 2001
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885C Obasaju, J Manola, G R Hudes, et al.
The British Journal of Surgery|January 1, 1974
Preliminary experience of bone scanning with 99mTc-labelled polyphosphate in malignant diseaseD L Citrin, W R Greig, J F Calder, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
The British Journal of Radiology|February 1, 1975
A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant diseaseD L Citrin, R G Bessent, J B Tuohy, et al.
The Prostate|January 1, 1991
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trialD L Citrin, M I Resnick, P Guinan, et al.
The British Journal of Surgery|April 1, 1974
Proceedings: Comparison of 99Tc-labelled polyphosphate, pyrophosphate and ethane hydroxydiphosphonate in patients with skeletal metastasesD L Citrin, R G Bessent, J B Tuohy, et al.
The British Journal of Surgery|September 1, 1978
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancerJ H McKillop, L H Blumgart, C B Wood, et al.
Strahlentherapie. Sonderbande|January 1, 1975
Comparison of 99mTc-labelled polyphosphate, pyrophosphate and ethane hydroxy diphosphonate in patients with skeletal metastases and in normal subjectsD L Citrin, R G Bessent, J B Tuohy, et al.
Pageof 6